| Literature DB >> 32010099 |
Shubo Yu1, Pengfei Yu1,2, Juan Wang3, Chun Li2, Hui Guo1,2, Chengcheng Liu1,2, Li Kong1,2, Leyi Yu2, Shi Wu1, Tao Lei1, Moutong Chen1, Haiyan Zeng1, Rui Pang1, Youxiong Zhang1, Xianhu Wei1, Jumei Zhang1, Qingping Wu1, Yu Ding1,2.
Abstract
Bacillus cereus is widely distributed in different food products and can cause a variety of symptoms associated with food poisoning. Since ready-to-eat (RTE) foods are not commonly sterilized by heat treatment before consumption, B. cereus contamination may cause severe food safety problems. In this study, we investigated the prevalence of B. cereus in RTE food samples from different regions of China and evaluated the levels of bacterial contamination, antibiotic resistance, virulence gene distribution, and genetic polymorphisms of these isolates. Of the tested retail RTE foods, 35% were positive for B. cereus, with 39 and 83% of the isolated strains harboring the enterotoxin-encoding hblACD and nheABC gene clusters, respectively. The entFM gene was detected in all B. cereus strains. The cytK gene was present in 68% of isolates, but only 7% harbored the emetic toxin-encoding gene cesB. Antimicrobial susceptibility testing revealed that the majority of the isolates were resistant not only to most β-lactam antibiotics, but also to rifamycin. Multilocus sequence typing (MLST) revealed that the 368 isolates belonged to 192 different sequence types (STs) including 93 new STs, the most prevalent of which was ST26. Collectively, our study indicates the prevalence, bacterial contamination levels, and biological characteristics of B. cereus isolated from RTE foods in China and demonstrates the potential hazards of B. cereus in RTE foods.Entities:
Keywords: Bacillus cereus; antibiotic resistance; genetic polymorphism; ready-to-eat food; risk assessment; virulence genes
Year: 2020 PMID: 32010099 PMCID: PMC6974471 DOI: 10.3389/fmicb.2019.03043
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Prevalence and contamination level of B cereus in different ready-to-eat foods.
| Cooked meat | 224/656(34) | 55/224(25) | 151/224(67) | 18/224(8) |
| Rice/noodles | 59/119(50) | 10/59(17) | 39/59(66) | 10/59(17) |
| Cold vegetable dishes in sauce | 19/85(22) | 2/19(11) | 16/19(84) | 1/19(5) |
| Total | 302/860(35) | 67/302(22) | 206/302(68) | 29/302(10) |
FIGURE 1Distribution of virulence genes in B. cereus isolated from ready-to-eat foods in China. The number at the top of the bars represents the positivity rate for the corresponding toxin genes. hblACD and nheABC indicate strains positive for hblA, hblC, and hblD, or nheA, nheB, and nheC, respectively.
FIGURE 2Characterization of virulence genes in B. cereus strains 2087-2-Bc and 3709-1A-Bc. Gel electrophoresis of PCR products of different virulence genes in B. cereus 2087-2-Bc (A) and B. cereus 3709-1A-Bc (B). S, sample; P, positive control; N, negative control.
FIGURE 3Antibiotic susceptibility of 368 B. cereus strains isolated from ready-to-eat foods in China. Different colors bars (blue, red, and green) represent the proportion of resistant, moderately resistant, and sensitive strains, respectively. The proportion of multidrug resistance (MDR) strains resistant to at least three, four, or five antibiotics is indicated by light gray, gray, or dark bars, respectively. AMP, ampicillin; P, penicillin; AMC, aoxicillin-clavulanic acid; KF, cephalothin; FOX, cefoxitin; RD, rifampin; DA, clindamycin; QD, quinupristin-dalfopristin; E, erythromycin; FD, nitrofurantoin; TE, tetracycline; CTT, cefotetan; SXT, trimethoprim-sulfamethoxazole; TEL, telithromycin; TEC, teicoplanin; CIP, ciprofloxacin; K, kanamycin; C, chloramphenicol; CN, gentamicin; IPM, imipenem.
Antibiotic susceptibility of 368 B. cereus strains isolated from ready-to-eat foods in China.
| β-Lactams | Penicillins | I | Ampicillin (10 μg) | 367(99.73%) | 0(0.00%) | 1(0.27%) |
| II | Penicillin (10 units) | 368(100.00%) | 0(0.00%) | 0(0.00%) | ||
| β-Lactam/β-lactamase inhibitor combinations | III | Amoxicillin-clavulanic acid (20 μg/10 μg) | 360(97.83%) | 0(0.00%) | 8(2.17%) | |
| Cephems (parenteral) | IV | Cephalothin (30 μg) | 303(82.34%) | 41(11.14%) | 24(6.52%) | |
| V | Cefoxitin (30 μg) | 351(95.38%) | 2(0.54%) | 15(4.08%) | ||
| VI | Cefotetan (30 μg) | 50(13.59%) | 63(17.12%) | 255(62.29%) | ||
| Penems | VII | Imipenem (10 μg) | 1(0.27%) | 0(0.00%) | 367(99.73%) | |
| Non β-Lactams | Aminoglycosides | VIII | Gentamicin (10 μg) | 7(1.90%) | 6(1.63%) | 355(96.47%) |
| IX | Kanamycin (30 μg) | 1(0.27%) | 86(23.37%) | 281(76.36%) | ||
| Macrolides | X | Erythromycin (15 μg) | 10(2.72%) | 206(55.98%) | 152(41.30%) | |
| Ketolide | XI | Telithromycin (15 μg) | 35(9.51%) | 62(16.85%) | 271(73.64%) | |
| Glycopeptides | XII | Teicoplanin (30 μg) | 7(1.90%) | 52(14.13%) | 309(83.97%) | |
| Quinolones | XIII | Ciprofloxacin (5 μg) | 4(1.09%) | 74(20.11%) | 290(78.80%) | |
| Phenylpropanol | XIV | Chloramphenicol (30 μg) | 5(1.36%) | 25(6.79%) | 338(91.85%) | |
| Tetracyclines | XV | Tetracycline (30 μg) | 57(15.49%) | 109(29.62%) | 202(54.89%) | |
| Folate pathway inhibitors | XVI | Trimethoprim-Sulfamethoxazole (1.25 μg/23.75 μg) | 46(12.50%) | 49(13.32%) | 273(74.18%) | |
| Lincosamides | XVII | Clindamycin (2 μg) | 34(9.24%) | 317(86.14%) | 17(4.62%) | |
| Ansamycins | XVIII | Rifampin (5 μg) | 343(93.21%) | 21(5.71%) | 4(1.09%) | |
| Streptogramins | XIX | Quinupristin-dalfopristin (15 μg) | 72(19.57%) | 254(69.02%) | 42(11.41%) | |
| Nitrofurans | XX | Nitrofurantoin (300 μg) | 61(16.58%) | 161(43.75%) | 146(39.67%) | |
| Pansusceptible | ≥3 Antimicrobia | 100.00% | ||||
| ≥4 Antimicrobia | 99.73% | |||||
| ≥5 Antimicrobia | 98.91% | |||||
FIGURE 4Minimum spanning tree and genetic diversity of 368 B. cereus strains isolated from ready-to-eat foods in China. Circles filled with red color represent different singletons and with other different colors represent different clonal complexes. The numbers inside the circle indicates the corresponding sequence type (ST). The color grading and corresponding number of the line indicate the change in seven sites between the two strains at both ends of the line. The circle with a larger diameter in each clonal complex is represented the dominant ST.